Rifampin has been shown to induce neuroprotection in AD by increasing Aβ clearance by upregulating low density lipoprotein receptor-related protein 1 (LRP-1) and P-glycoprotein (P-gp) [44]. Here, ABCB1 is linked to Alzheimer disease.